PDGFRβ is an essential therapeutic target for BRCA1-deficient mammary tumors.
Bai F, Liu S, Liu X, Hollern DP, Scott A, Wang C, Zhang L, Fan C, Fu L, Perou CM, Zhu WG, Pei XH.
Bai F, et al. Among authors: pei xh.
Breast Cancer Res. 2021 Jan 21;23(1):10. doi: 10.1186/s13058-021-01387-x.
Breast Cancer Res. 2021.
PMID: 33478572
Free PMC article.